Coronary angioplasty and Rotablator atherectomy trial (CARAT): Immediate and late results of a prospective multicenter randomized trial

医学 揭穿 血运重建 动脉切除术 血管成形术 外科 病变 管腔(解剖学) 再狭窄 临床终点 放射科 冠状动脉疾病 经皮 靶病变 随机对照试验 经皮冠状动脉介入治疗 心脏病学 内科学 支架 心肌梗塞 癌症 卵巢癌
作者
Robert D. Safian,Ted Feldman,David W.M. Muller,Denise Mason,Theodore Schreiber,Bruce Haik,M. Mooney,William W. O’Neill
出处
期刊:Catheterization and Cardiovascular Interventions [Wiley]
卷期号:53 (2): 213-220 被引量:162
标识
DOI:10.1002/ccd.1151
摘要

Abstract Mechanical rotational atherectomy with the Rotablator is widely used for percutaneous coronary revascularization, but the ideal debulking strategy remains unknown. The purpose of this study was to compare the immediate and late results after Rotablator using two treatment strategies: Large burrs (burr/artery ratio of >0.7) to achieve maximal debulking (lesion debulking strategy) or small burrs (burr/artery ratio ≤ 0.7) to modify lesion compliance (lesion modification strategy). Two hundred twenty‐two patients at six centers were prospectively enrolled in this study and randomly assigned to large (n = 104 patients with 118 lesions) or small (n = 118 patients with 136 lesions) burrs. The primary endpoint was final diameter stenosis at the end of the procedure, and secondary endpoints included inhospital angiographic and clinical complications, and target lesion revascularization at 6 months. Baseline demographic and angiographic characteristics were similar. There were no differences in procedural success, the extent of immediate lumen enlargement, inhospital ischemic complications, or late target vessel revascularization. However, compared with small burrs, patients randomized to large burrs were more likely to experience serious angiographic complications (5.1% vs. 12.7%, P < 0.05) immediately after atherectomy. This study suggests that a routine lesion modification strategy employing small burrs (burr/artery ratio ≤ 0.7) achieves similar immediate lumen enlargement and late target vessel revascularization compared with a more aggressive debulking strategy (burr/artery ratio >0.7), but with fewer angiographic complications. Cathet Cardiovasc Intervent 2001;53:213–220. © 2001 Wiley‐Liss, Inc.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
优雅的流沙完成签到 ,获得积分10
1秒前
猫的海完成签到,获得积分10
1秒前
1秒前
Eason Liu完成签到,获得积分0
2秒前
Wendy1204完成签到,获得积分20
2秒前
Hello应助654采纳,获得10
2秒前
咩咩羊完成签到,获得积分10
2秒前
6秒前
lianqing完成签到,获得积分10
6秒前
汉堡包应助科研通管家采纳,获得10
6秒前
领导范儿应助科研通管家采纳,获得10
7秒前
RC_Wang应助科研通管家采纳,获得10
7秒前
科研通AI5应助科研通管家采纳,获得10
7秒前
所所应助科研通管家采纳,获得10
7秒前
FashionBoy应助科研通管家采纳,获得10
7秒前
赘婿应助科研通管家采纳,获得10
7秒前
hh应助科研通管家采纳,获得10
7秒前
所所应助科研通管家采纳,获得10
7秒前
丘比特应助科研通管家采纳,获得10
7秒前
搜集达人应助科研通管家采纳,获得30
7秒前
7秒前
Leif应助科研通管家采纳,获得20
7秒前
7秒前
8秒前
8秒前
9秒前
9秒前
忘羡222发布了新的文献求助20
10秒前
丰富猕猴桃完成签到,获得积分10
11秒前
11秒前
11秒前
11秒前
JamesPei应助咿咿呀呀采纳,获得10
11秒前
www完成签到,获得积分10
11秒前
科研通AI2S应助Jenny采纳,获得10
12秒前
limin完成签到,获得积分10
13秒前
13秒前
风格完成签到,获得积分10
14秒前
情怀应助专心搞学术采纳,获得20
15秒前
15秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527990
求助须知:如何正确求助?哪些是违规求助? 3108173
关于积分的说明 9287913
捐赠科研通 2805882
什么是DOI,文献DOI怎么找? 1540119
邀请新用户注册赠送积分活动 716941
科研通“疑难数据库(出版商)”最低求助积分说明 709824